Log In
Print
BCIQ
Print
Print this Print this
 

AFM13

  Manage Alerts
Collapse Summary General Information
Company Affimed N.V.
DescriptionTetravalent bispecific human antibody targeting CD30 and Fc gamma receptor IIIa (CD16a; FCGR3A; FcgammaRIIIa)
Molecular Target CD30 ; Fc gamma receptor IIIa (FCGR3A) (FcgammaRIIIa) (CD16a)
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today